Cortico-dependence is frequent in giant cell arteritis patients, and no drugs has proved its ability to prevent corticodependence. Hydrocychloroquine is a well tolerated immunomodulatory drug that may have a corticosteroid sparing potential according to immuno-pharmacological and clinical data. We have designed a multcentric double blind versus placebo randomized controled trial to assess the corticosteroid sparing effect of hydroxychloroquine in non complicated giant cell arteritis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
75
Hospital
Agen, France
Hospital
Albi, France
prednisone dosage equal to or lower than 5 mg since more than 3 months without
Time frame: 3 months at least
having experienced relapse since the inclusion in the study
prednisone daily dosage
Time frame: 6, 12, 18 and 24 months
hydroxychloroquine blood levels
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Auch
Auch, France
Hospital Avignon
Avignon, France
University Hospital Besançon
Besançon, France
Hospital Béziers
Béziers, France
University Hospital Côte de Nacre
Caen, France
University Hospital Dijon
Dijon, France
Hospital
Foix, France
Hospital
Lavaur, France
...and 13 more locations